Radiotherapy Market will grow by 5.72% CAGR from 2021-2030

by Talib Hussain Digital Marketing Specialist

Radiotherapy, or Radiation therapy, is regarded as a treatment that uses ionizing radiation to regulate or destroy malignant cells. It is typically administered as part of cancer treatment and is typically administered via a linear accelerator. At a range of very low doses, radiation is widely used in the X-rays to have a transparent look at the inside of a human body, as with the X-rays of broken bones & teeth.

 

The Radiotherapy Market worth was $ 6.52 billion in 2021 & will value at $ 10.72 billion by 2030, at almost 5.72% CAGR. 

 

The primary benefit of radiation is that it might aid in limiting the spread of cancer. A limited percentage of patients with locally advanced pancreatic cancer and borderline resectable cancer may benefit from radiation to facilitate surgery. For SABR, each therapy session will last around 30 minutes or longer.

 

 

Radiotherapy future and related statistics.

 

·       Radiation therapy is used to treat cancer in more than 50% of all cancer patients. Radiation therapy is a common cancer treatment used by medical professionals. Some benign (noncancerous) tumors can benefit from radiation therapy. Moreover, there are a plethora of aspects of radiation oncology, but on the other side, there are still some concerns regarding the future of this particular field. Hence, the employment rate in this sector is rising abruptly, and already a plethora of trainees have been enrolled in the same. A survey has revealed that for accuracy, estimations are compared against data from the BLS, Census, and current job vacancies. The data science team at Zippia discovered the following after doing a thorough investigation and analysis: There are currently over 14,753 radiation therapists working in the United States.

 

·       The Bureau of Labor Statistics predicts that employment in radiation therapy will increase by 9% by 2028, outpacing the national average. Alternative therapies like minimally invasive surgery and other local therapies will compete with radiotherapy. The advanced disease will be treated using multimodal, customized, curative, and palliative approaches.

 

 

Segments incorporated in this report:-

 

Type

 

• Systemic Radiation therapy
• External Beam Radiation Therapy
• Internal Beam Radiation Therapy

 

Applications

 

• Breast Cancer
• Skin and Lip Cancer 
• Spine Cancer
• Lung Cancer
• Prostate Cancer
• Cervical Cancer
• SCLC (Small Cell Lung Cancer) 
• Head & Neck Cancer 

 

Equipment

 

• Treatment Planning Systems
• Linear Accelerators
• Radiation Therapy Simulators

 

End-User

• ASCs
• Hospitals
• Others

 

Players involved:

 

• GE Healthcare
• Hitachi Ltd.
• ZEISS Group
• ICAD, Inc.
• Accuray, Inc.
• Becton, Dickinson, and Company
• ViewRay, Inc.
• Eckert & Ziegler
• IsoRay Medical, Inc.

 

 

Recent Development

 

• On April 2022, the radiation oncology collaboration between Elekta and GE Healthcare was announced. Elekta and GE Healthcare are confident that their partnership will enable hospitals to offer comprehensive imaging and therapeutic options for patients who require radiotherapy.

 

• On Feb 2022, The SOGAZ insurance organization and Ion Beam Applications SA (IBA) partnered to install Ion Beam Applications' Proteus ONE proton therapy system in Saint Petersburg, Russia. IBA and Sogaz think that by working together, more Russian patients will have access to radiotherapy.

Sponsor Ads

• Ad Space Available - Rent it Now!

Created on Nov 15th 2022 06:19. Viewed 166 times.

Comments